Skip to main content
SpringerLink
Log in

Dibotermin-α delivers for fractures and spinal fusion

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Alt V, Bentley A, Schnettler R.Savings of the use of RHBMP-2 in open tibia fractures for European health care systems from a payer and societal perspective. Value in Health 10: A184 (plus poster) abstr. PSU3, No. 3, May-Jun 2007

  2. Alt V, Chhabra A, Nicklasson L, Greenberg D, Schnettler R.Cost-effectiveness analysis of RHBMP-2 in the treatment of open tibia fractures in Sweden and Denmark. Value in Health 10: A183 (plus poster) abstr. PSU2, No. 3, May-Jun 2007

  3. Chhabra A, Nicklasson L, Greenberg D, Alt V.A cost-effectiveness analysis of RHBMP-2 in spine fusion surgery in Sweden and Denmark. Value in Health 10: A97, No. 3, May-Jun 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dibotermin-α delivers for fractures and spinal fusion. Pharmacoecon. Outcomes News 532, 3–4 (2007). https://doi.org/10.2165/00151234-200705320-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705320-00004

Keywords

Search

Navigation